Diazyme acquires Carolina Liquid Chemistries
June 3, 2026—Diazyme Laboratories has acquired Carolina Liquid Chemistries Corp., an FDA-registered manufacturer and reseller of chemistry systems and reagents.
Webinars and Sponsored Roundtables — Register Now
Tuesday, June 9, 2026, 1:00–2:00 PM ET
In this webinar, we will examine how immune recognition after allogeneic HCT can influence leukemia relapse and disease progression. The session will highlight the clinical relevance of HLA loss of heterozygosity (LOH), approaches used for its detection, and how LOH findings may support transplant strategies, including considerations for donor selection in subsequent transplantation.
Webinar presenter Alberto Cardoso Martins Lima, PhD, Clinical consulting scientist in histocompatibility,
specializing in allogeneic hematopoietic cell transplantation (HCT) at IGEN/AFIP São Paulo and CHC/UFPR in Curitiba, Brazil
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenter Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, July 15, 2026, 1:00-2:00 PM ET
Hear an expert discuss how to integrate Kappa and Lambda in situ hybridization testing into your standard hematopathology workflow to accurately assess B-cell and plasma cell clonality. You will also gain the skills to recognize testing pitfalls in challenging reactive versus neoplastic proliferations and apply ancillary tools to resolve complex cases.
Webinar presenter Xiaojun Wu, MD, PhD, Assistant professor, Director of Hematopathology Section at NCR of Johns Hopkins Medicine Department of Pathology, SOM at Johns Hopkins University
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Industry News
Sysmex America introduces XR-Series hematology solution
June 2, 2026—Sysmex America has introduced the XR-Series, a hematology solution designed to help laboratories deliver fast, reliable results while maintaining efficient workflows.
Leica Biosystems, Indica Labs partner with Lunit
May 29, 2026—Leica Biosystems, Indica Labs, and Lunit are partnering to develop AI-powered image analysis algorithms.
Seegene launches CE-marked Allplex MDRO assay
May 28, 2026—Seegene launched its new antimicrobial resistance testing product, the Allplex MDRO assay.
Horiba launches Yumivet VH2500 hematology analyzer
May 27, 2026—Horiba has launched Yumivet, its new veterinary diagnostics brand, and introduced the Yumivet VH2500 hematology analyzer.
FujiFilm, mTuitive partner to integrate technologies
May 26, 2026—FujiFilm Healthcare Americas has announced a strategic partnership with mTuitive under which it will integrate mTuitive’s structured pathology reporting platform with FujiFilm’s Synapse Pathology picture archiving and communication system.
Grundium acquires Visiopharm, adding AI software to its scanner portfolio
May 21, 2026—Finland’s Grundium, backed by U.S.-based health care private equity firm EW Healthcare Partners, has acquired Visiopharm, of Denmark.
Anchor Molecular releases BCR-ABL1 control panels
May 20, 2026—Anchor Molecular launched its BCR-ABL1 control panels designed to support laboratories in monitoring the performance of the quantitative detection of BCR-ABL1 translocation mRNA transcripts.
Streck gets IVD clearance for MDx-Chex controls, launches blood culture tube
May 19, 2026—Streck has received in vitro diagnostic clearance for three MDx-Chex controls for sepsis testing.
FDA OK’s Signatera CDx for muscle-invasive bladder cancer
May 18, 2026—The FDA has approved Natera’s Signatera CDx as a companion diagnostic for use with adjuvant atezolizumab (Tecentriq) immunotherapy in muscle-invasive bladder cancer to identify patients who are ctDNA molecular residual disease–positive and may benefit from treatment.